Y. Ogawa

发表

Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.

T. Ishihara, Y. Mizushima, M. Higaki, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.

Y. Yamaguchi, M. Takenaga, Y. Mizushima, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.

H. Okada, T. Shimamoto, Masaki Yamamoto, 1988, Chemical & pharmaceutical bulletin.

Heat-Induced Drug Release Rate and Maximal Targeting Index of Thermosensitive Liposome in Tumor-Bearing Mice

H. Toguchi, K. Iga, Y. Ogawa, 1992, Pharmaceutical Research.

Administration of Optimum Sustained-Insulin Release PLGA Microcapsules to Spontaneous Diabetes-Prone BB/WorTky Rats

Y. Yamaguchi, M. Takenaga, K. Komeda, 2006, Drug delivery.

Optimum formulation for sustained-release insulin.

Y. Yamaguchi, M. Takenaga, Y. Mizushima, 2004, International journal of pharmaceutics.

A novel insulin formulation can keep providing steady levels of insulin for much longer periods in‐vivo

Y. Yamaguchi, M. Takenaga, Y. Mizushima, 2002, The Journal of pharmacy and pharmacology.

A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release.

Y. Yamaguchi, M. Takenaga, Y. Mizushima, 2002, Journal of controlled release : official journal of the Controlled Release Society.

In vitro release test system of (d,l-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin)

S. Kamei, Y. Igari, A. Saikawa, 1996 .

Rates of Systemic Degradation and Reticuloendothelial System (RES) Uptake of Thermosensitive Liposome Encapsulating Cisplatin in Rats

H. Toguchi, K. Iga, Y. Ogawa, 1993, Pharmaceutical Research.

Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34).

Y. Matsumoto, K. Iga, T. Fukuda, 2002, Journal of pharmaceutical sciences.

Pharmacokinetics of Once-a-Month Injectable Microspheres of Leuprolide Acetate

H. Okada, T. Heya, H. Toguchi, 1991, Pharmaceutical Research.

Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs.

T. Ikoma, K. Hoshi, T. Ishihara, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Ultrafiltration Method for Measuring Free Preservatives in Aqueous Phase of Oil-in-Water Emulsions

T. Shimamoto, Y. Ogawa, N. Ohkura, 1973 .

Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals

H. Okada, T. Heya, T. Shimamoto, 1989, The Journal of pharmacy and pharmacology.

One-month release injectable microspheres of leuprolide acetate inhibit steroidogenesis and genital organ growth in rats

H. Okada, T. Heya, T. Shimamoto, 1989 .

Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers

H. Okada, H. Toguchi, Y. Ogawa, 2004, Pharmaceutical Research.

Utilization of an Amorphous Form of a Water-Soluble GPIIb/IIIa Antagonist for Controlled Release from Biodegradable Microspheres

Y. Ogawa, Shigeyuki Takada, K. Miyazaki, 1997, Pharmaceutical Research.

Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1–34)

Y. Matsumoto, K. Iga, N. Higo, 2001, The Journal of pharmacy and pharmacology.

Evaluation of Oral Mucoadhesive Microspheres in Man on the Basis of the Pharmacokinetics of Furosemide and Riboflavin, Compounds with Limited Gastrointestinal Absorption Sites

J. Azuma, I. Yamamoto, Y. Ogawa, 1998, The Journal of pharmacy and pharmacology.

Estimation of drug absorption rates using a deconvolution method with nonequal sampling times

Yasuaki Ogawa, T. Shimamoto, K. Iga, 1986, Journal of Pharmacokinetics and Biopharmaceutics.

Sustained Suppression of the Pituitary-Gonadal Axis by Leuprorelin Three-Month Depot Microspheres in Rats and Dogs

H. Okada, H. Toguchi, Y. Ogawa, 1994, Pharmaceutical Research.

Sustained Pharmacological Activities in Rats Following Single and Repeated Administration of Once-a-Month Injectable Microspheres of Leuprolide Acetate

H. Okada, T. Heya, T. Shimamoto, 1991, Pharmaceutical Research.

Sustained release of a water-soluble GP IIb/IIIa antagonist from copoly(dl-lactic/glycolic)acid microspheres

Y. Ogawa, T. Kurokawa, Shigeyuki Takada, 1997 .

Fluorinated polymer coatings on PLGA microcapsules for drug delivery system using atmospheric pressure glow plasma

Kunihito Tanaka, M. Kogoma, Y. Ogawa, 2006 .

Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.

Y. Ogawa, Y. Shibamoto, Y. Nishimura, 1990, Radiation research.

A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.

T Yashiki, H. Okada, Y. Ogawa, 1988, Chemical & pharmaceutical bulletin.

New method for analysis of biodegradable polyesters by high-performance liquid chromatography after alkali hydrolysis.

H. Okada, H. Toguchi, S. Kamei, 1992, Biomaterials.

In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.

H. Okada, Y. Ogawa, T. Shimamoto, 1988, Chemical & pharmaceutical bulletin.

Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2',5'-oligoadenylate synthetase activity in murine liver.

Y. Ogawa, Y. Yamagata, Kazumichi Yamamoto, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.